Chaudhary R, Suhan T, Wu C, Alzamrooni A, Madamanchi N, Abdel-Latif A
Mol Cell Endocrinol. 2025; 598:112457.
PMID: 39788312
PMC: 11820722.
DOI: 10.1016/j.mce.2025.112457.
De Matteis G, Burzo M, Serra A, Della Polla D, Nicolazzi M, Simeoni B
Intern Emerg Med. 2024; 20(1):95-104.
PMID: 39225848
PMC: 11794344.
DOI: 10.1007/s11739-024-03754-w.
Thomson R, Grafton-Clarke C, Matthews G, Swoboda P, Swift A, Frangi A
ESC Heart Fail. 2024; 11(6):4148-4159.
PMID: 39132877
PMC: 11631267.
DOI: 10.1002/ehf2.15011.
Riemma M, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G
Front Pharmacol. 2024; 15:1422740.
PMID: 38948473
PMC: 11212466.
DOI: 10.3389/fphar.2024.1422740.
Nakamori S, Kucukseymen S, Rodriguez J, Yazdanian F, Ngo L, Gopal D
JACC Adv. 2024; 2(10):100730.
PMID: 38938495
PMC: 11198377.
DOI: 10.1016/j.jacadv.2023.100730.
Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology Registry.
Bae J, Kallenbach L, Nelson D, Lavelle K, Winer-Jones J, Bonafede M
BMC Endocr Disord. 2024; 24(1):59.
PMID: 38693484
PMC: 11064285.
DOI: 10.1186/s12902-024-01589-2.
New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review.
Jalil J, Gabrielli L, Ocaranza M, MacNab P, Fernandez R, Grassi B
Int J Mol Sci. 2024; 25(8).
PMID: 38673991
PMC: 11049921.
DOI: 10.3390/ijms25084407.
Is atrial fibrillation in HFpEF a distinct phenotype? Insights from multiparametric MRI and circulating biomarkers.
Dattani A, Brady E, Kanagala P, Stoma S, Parke K, Marsh A
BMC Cardiovasc Disord. 2024; 24(1):94.
PMID: 38326736
PMC: 10848361.
DOI: 10.1186/s12872-024-03734-0.
Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.
Stoicescu L, Crisan D, Morgovan C, Avram L, Ghibu S
Int J Mol Sci. 2024; 25(2).
PMID: 38255869
PMC: 10815792.
DOI: 10.3390/ijms25020794.
Exercise intolerance in heart failure with preserved ejection fraction: Causes, consequences and the journey towards a cure.
Bunsawat K, Nelson M, Hearon Jr C, Wray D
Exp Physiol. 2023; 109(4):502-512.
PMID: 38063130
PMC: 10984794.
DOI: 10.1113/EP090674.
Insights into the Interaction of Heart Failure with Preserved Ejection Fraction and Sleep-Disordered Breathing.
Wester M, Arzt M, Sinha F, Maier L, Lebek S
Biomedicines. 2023; 11(11).
PMID: 38002038
PMC: 10669157.
DOI: 10.3390/biomedicines11113038.
Large animal models to study effectiveness of therapy devices in the treatment of heart failure with preserved ejection fraction (HFpEF).
Fisher S, Murally A, Rajabally Z, Almas T, Azhar M, Cheema F
Heart Fail Rev. 2023; 29(1):257-276.
PMID: 37999821
DOI: 10.1007/s10741-023-10371-w.
Genome-Wide Association Study of Pericardial Fat Area in 28 161 UK Biobank Participants.
Salih A, Ardissino M, Wagen A, Bard A, Szabo L, Ryten M
J Am Heart Assoc. 2023; 12(21):e030661.
PMID: 37889180
PMC: 10727393.
DOI: 10.1161/JAHA.123.030661.
Cardiac reverse remodelling by imaging parameters with recent changes to guideline medical therapy in heart failure.
Kodsi M, Makarious D, Gan G, Choudhary P, Thomas L
ESC Heart Fail. 2023; 10(6):3258-3275.
PMID: 37871982
PMC: 10682888.
DOI: 10.1002/ehf2.14555.
Biomarker Phenotypes in Heart Failure with Preserved Ejection Fraction Using Hierarchical Clustering-A Pilot Study.
Mitic V, Stojanovic D, Deljanin-Ilic M, Petrovic D, Ignjatovic A, Milenkovic J
Med Princ Pract. 2023; .
PMID: 37734333
PMC: 10659697.
DOI: 10.1159/000534155.
Neural control of the circulation during exercise in heart failure with reduced and preserved ejection fraction.
Bunsawat K, Skow R, Kaur J, Wray D
Am J Physiol Heart Circ Physiol. 2023; 325(5):H998-H1011.
PMID: 37682236
PMC: 10907034.
DOI: 10.1152/ajpheart.00214.2023.
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
Cochran J, Yura Y, Thel M, Doviak H, Polizio A, Arai Y
Circulation. 2023; 148(15):1165-1178.
PMID: 37681311
PMC: 10575571.
DOI: 10.1161/CIRCULATIONAHA.123.064170.
Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction.
Park K, Park T
Int J Cardiol Cardiovasc Risk Prev. 2023; 18:200201.
PMID: 37575339
PMC: 10415684.
DOI: 10.1016/j.ijcrp.2023.200201.
The concurrent impact of mild cognitive impairment and frailty syndrome in heart failure.
Uchmanowicz I, Rosano G, Piepoli M, Vellone E, Czapla M, Lisiak M
Arch Med Sci. 2023; 19(4):912-920.
PMID: 37560724
PMC: 10408025.
DOI: 10.5114/aoms/162369.
Inflammation as a therapeutic target in heart failure with preserved ejection fraction.
Peh Z, Dihoum A, Hutton D, Arthur J, Rena G, Khan F
Front Cardiovasc Med. 2023; 10:1125687.
PMID: 37456816
PMC: 10339321.
DOI: 10.3389/fcvm.2023.1125687.